Renalytix AI, Inc.

Renalytix AI, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on June 29, 2023 and the most recent on June 29, 2023 (KidneyIntelX.dkd). Its most common review panel is Clinical Chemistry (1 device).